Acceptability and safety of two sequential doses of psilocybin in bipolar II depression: protocol for an open-label single-arm feasibility study

Paper. Meyer TD, Vale LN, Ibrahim M et al.. BMJ Open, 13 Jul 2026.

Tags: Human, Clinical trial, Psilocybin, Depression, Bipolar.